Aeglea BioTherapeutics, Inc. Gains 61.4%
Fri, Oct 28, 2022 at 07:31 PM
Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ) shot up at $0.92, a gain of 61.4%. On Fri, Oct 28, 2022, AGLE:NASDAQ touched a New 2-Week High of $0.92. The stock got featured on our News Catalysts scanner on Fri, Oct 21, 2022 at 02:50 PM in the 'ACQUISITION' category. From Fri, Oct 14, 2022, the stock recorded 50.00% Up Days and 63.64% Green Days
About Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ)
Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.
Top 10 Gainers:
- Quanergy Systems Inc. (QNGY:NYSE), 153.85%
- Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ), 61.4%
- Nuvalent Inc. (NUVL:NASDAQ), 60.64%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Fangdd Network Group Ltd. (DUO:NASDAQ), 36.62%
- Provident Acquisition Corp. (PAQC:NASDAQ), 32.69%
- Rail Vision Ltd. (RVSN:NASDAQ), 27.9%
- Sierra Metals Inc. (SMTS:NYSEMKT), 27.81%
- Viomi Technology Co., Ltd (VIOT:NASDAQ), 24.97%
- Data I/O Corporation (DAIO:NASDAQ), 23.38%